title: Influenza and parainfluenza viral infections in children.
abstract: • On the basis of strong epidemiologic evidence, influenza and parainfluenza viruses are responsible for significant morbidity and mortality in young infants and children and in persons with chronic medical conditions. (1)(4)(26)(27)(35). • On the basis of research evidence, influenza vaccines are effective in preventing disease in high-risk individuals. (8)(17)(18). • On the basis of strong research evidence, influenza vaccines are safe in young infants and children 6 months or older. (8)(15).• On the basis of research evidence, the use of corticosteroids and epinephrine is beneficial in the treatment of laryngotracheitis caused by parainfluenza viruses. (44)(45)(46)(47). • Strong evidence supports the use of influenza vaccines in pregnant mothers as a strategy to prevent disease in infants younger than 6 months. (17)(18)(19).
authors.affiliation: Department of Pediatrics, Ryan White Center for Pediatric Infectious Disease, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN.
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Fox
authors.affiliation: Department of Pediatrics, Ryan White Center for Pediatric Infectious Disease, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN.
authors.forename: John C
authors.initials: JC
authors.lastname: Christenson
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control*; D022241:Parainfluenza Vaccines / Q000008:administration & dosage*; D018184:Paramyxoviridae Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D022241:Parainfluenza Vaccines